Rita Lombardi

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Dual inhibition of mTOR and HSP90 enhances cisplatin efficacy and overcomes resistance in ovarian cancer.

Dual inhibition of mTOR and HSP90 enhances cisplatin efficacy and overcomes resistance in ovarian cancer.

Journal: Cell death & disease

Published: August 01, 2025

Valproic acid improves the efficacy of oxaliplatin/fluoropyrimidine-based chemotherapy by targeting cancer stem cell via β-Catenin modulation in colorectal cancer.

Valproic acid improves the efficacy of oxaliplatin/fluoropyrimidine-based chemotherapy by targeting cancer stem cell via β-Catenin modulation in colorectal cancer.

Journal: Cell death & disease

Published: April 27, 2025

Serum-Based Proteomic Approach to Identify Clinical Biomarkers of Radiation Exposure.

Serum-Based Proteomic Approach to Identify Clinical Biomarkers of Radiation Exposure.

Journal: Cancers

Published: December 30, 2024

Proteomic Analysis of Biomarkers Predicting Treatment Response in Patients with Head and Neck Cancers.

Proteomic Analysis of Biomarkers Predicting Treatment Response in Patients with Head and Neck Cancers.

Journal: International journal of molecular sciences

Published: October 25, 2024

Integrated proteomics and metabolomics analyses reveal new insights into the antitumor effects of valproic acid plus simvastatin combination in a prostate cancer xenograft model associated with downmodulation of YAP/TAZ signaling.

Integrated proteomics and metabolomics analyses reveal new insights into the antitumor effects of valproic acid plus simvastatin combination in a prostate cancer xenograft model associated with downmodulation of YAP/TAZ signaling.

Journal: Cancer cell international

Published: March 12, 2024

Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models.

Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models.

Journal: Journal of translational medicine

Published: April 06, 2022

An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer.

An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer.

Journal: Cancers

Published: January 05, 2022

Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors.

Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors.

Journal: Cancers

Published: December 23, 2021

HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer.

HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer.

Journal: Molecular oncology

Published: September 23, 2020

Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.

Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 30, 2020

Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance.

Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance.

Journal: Frontiers in cell and developmental biology

Published: April 01, 2020

Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.

Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 08, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026